Superseded 7/1/2026
222 words·~1 min read·
/ut/title-4/chapter-41/7-2A research copy — for the controlling text, always check the official state or federal source. Not legal advice.
Effective 5/6/2026
Superseded 7/1/2026
4-41-402. Cannabinoid sales and use authorized.
(1)The sale or use of a cannabinoid product is prohibited:
(a)except as provided in this chapter; or
(b)unless the United States Food and Drug Administration approves the product.
(2)The department shall keep a list of registered cannabinoid products that the department has determined, in accordance with Section 4-41-403 , are safe for human consumption.
(a)A person may sell or use a cannabinoid product that is in the list of registered cannabinoid products described in Subsection
(2).
(b)An individual may use cannabidiol or a cannabidiol product that is not in the list of registered cannabinoid products described in Subsection
(2)if:
(i)the individual purchased the product outside the state; and
(ii)the product's contents do not violate Title 58, Chapter 37, Controlled Substances, or Title 76, Chapter 18, Part 2, Offenses Concerning Controlled Substances.
(4)Any marketing for a cannabinoid product shall include a notice to consumers that the product is hemp or CBD and is not cannabis or medical cannabis, as those terms are defined in Section 26B-4-201 .
(5)A cannabinoid product that is designed to be inhaled shall include a warning on the label regarding the possible health effects of inhaling cannabinoid products.
Amended by Chapter 362 , 2026 General Session